Trusted News Discovery Since 2008
{{/content}}
Study Suggests Johnson & Johnson Vaccine Is Significantly Less Effective Against Delta Variant
Video Credit: KDKA CBS 2 Pittsburgh
Published on July 21, 2021 - Duration: 03:37s
Study Suggests Johnson & Johnson Vaccine Is Significantly Less Effective Against Delta Variant
After weeks of minimal reported coronavirus cases, the numbers are trending back up.
In fact, statewide cases are up over 80 percent in the last week.
And a new study suggests the Johnson & Johnson vaccine is significantly less effective against this variant; KDKA's Nicole Ford reports.
You are here
Related news from verified sources
The Johnson & Johnson single-shot COVID-19 vaccine jab generated strong, persistent activity against the Delta variant and other highly prevalent SARS-CoV-2...
on July 2, 2021 • Zee News
Phase-III trials of Covaxin, made by Hyderabad's Bharat Biotech showed it was 93.4% effective against severe symptomatic Covid-19, the firm said on Saturday. The...
on July 3, 2021 • IndiaTimes
86 percent of the people who got the infection after taking the coronavirus vaccine were found to have a delta variant of the virus.
on July 16, 2021 • DNA
Related videos from verified sources
Travelers At Logan Airport Cautious About Catching COVID Delta Variant On Summer Trips 02:11
Video credit: WBZ CBS Boston - Published on July 31, 2021
Event In Brooklyn Promotes COVID Testing, Vaccinations 02:23
Video credit: CBS 2 New York - Published on July 31, 2021
Delta variant blamed for spike in COVID cases in US 01:04
Video credit: WTVR - Scripps - Published on July 31, 2021